IsoMAG-An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells

被引:7
|
作者
Gribko, Alena [1 ]
Stiefel, Janis [2 ]
Liebetanz, Lana [2 ]
Nagel, Sophie Madeleine [1 ]
Kuenzel, Julian [3 ]
Wandrey, Madita [1 ]
Hagemann, Jan [1 ]
Stauber, Roland H. [1 ]
Freese, Christian [2 ]
Guel, Desiree [1 ]
机构
[1] Univ Med Ctr Mainz, Dept Otorhinolaryngol, Langenbeckstr 1, D-55131 Mainz, Germany
[2] Fraunhofer Inst Microengn & Microsyst IMM, Carl Zeiss Str 18-20, D-55129 Mainz, Germany
[3] Univ Hosp Regensburg, Dept Otorhinolaryngol, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany
关键词
automation; liquid biopsy; circulating tumor cells; head and neck squamous cell carcinoma; immunomagnetic particle-based detection; metastasis; METASTATIC BREAST-CANCER; HEAD; NECK; NANOMATERIAL; ENRICHMENT; CAPTURE; BLOOD;
D O I
10.3390/diagnostics11112040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: detailed information about circulating tumor cells (CTCs) as an indicator of therapy response and cancer metastasis is crucial not only for basic research but also for diagnostics and therapeutic approaches. Here, we showcase a newly developed IsoMAG IMS system with an optimized protocol for fully automated immunomagnetic enrichment of CTCs, also revealing rare CTC subpopulations. Methods: using different squamous cell carcinoma cell lines, we developed an isolation protocol exploiting highly efficient EpCAM-targeting magnetic beads for automated CTC enrichment by the IsoMAG IMS system. By FACS analysis, we analyzed white blood contamination usually preventing further downstream analysis of enriched cells. Results: 1 mu m magnetic beads with tosyl-activated hydrophobic surface properties were found to be optimal for automated CTC enrichment. More than 86.5% and 95% of spiked cancer cells were recovered from both cell culture media or human blood employing our developed protocol. In addition, contamination with white blood cells was minimized to about 1200 cells starting from 7.5 mL blood. Finally, we showed that the system is applicable for HNSCC patient samples and characterized isolated CTCs by immunostaining using a panel of tumor markers. Conclusion: Herein, we demonstrate that the IsoMAG system allows the detection and isolation of CTCs from HNSCC patient blood for disease monitoring in a fully-automated process with a significant leukocyte count reduction. Future developments seek to integrate the IsoMAG IMS system into an automated microfluidic-based isolation workflow to further facilitate single CTC detection also in clinical routine.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] CHARACTERIZATION OF LUNG SQUAMOUS-CELL CARCINOMA-DERIVED T-CELL SUPPRESSIVE FACTOR
    YOSHINO, I
    YANO, T
    MIYAMOTO, M
    YAMADA, K
    KAJII, Y
    ONODERA, K
    ISHIDA, T
    SUGIMACHI, K
    KIMURA, G
    NOMOTO, K
    [J]. CANCER, 1993, 72 (08) : 2347 - 2357
  • [22] EGFR as a marker for head and neck squamous cell carcinoma-derived small extracellular vesicles
    Dombroski, Jenna A.
    Kuhnell, Damaris
    Kasper, Susan
    Langevin, Scott M.
    [J]. CANCER RESEARCH, 2017, 77
  • [23] Suppressive effect of overexpressed connective tissue growth factor on tumor cell growth in a human oral squamous cell carcinoma-derived cell line
    Moritani, NH
    Kubota, S
    Nishida, T
    Kawaki, H
    Kondo, S
    Sugahara, T
    Takigawa, M
    [J]. CANCER LETTERS, 2003, 192 (02) : 205 - 214
  • [24] Cell Isolation System for Rare Circulating Tumor Cell
    Masuda, Taisuke
    Yilling, Sun
    Eui, Song Won
    Niimi, Miyako
    Yusa, Akiko
    Nakanishi, Hayao
    Arai, Fumihito
    [J]. 2014 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2014), 2014, : 4698 - 4703
  • [25] Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method
    Bozzetti, Cecilia
    Quaini, Federico
    Squadrilli, Anna
    Tiseo, Marcello
    Frati, Caterina
    Lagrasta, Costanza
    Azzoni, Cinzia
    Bottarelli, Lorena
    Galetti, Maricla
    Alama, Angela
    Belletti, Silvana
    Gatti, Rita
    Passaro, Antonio
    Gradilone, Angela
    Cavazzoni, Andrea
    Alfieri, Roberta
    Petronini, Pier Giorgio
    Bonelli, Mara
    Falco, Angela
    Carubbi, Cecilia
    Pedrazzi, Giuseppe
    Nizzoli, Rita
    Naldi, Nadia
    Pinto, Carmine
    Ardizzoni, Andrea
    [J]. PLOS ONE, 2015, 10 (11):
  • [26] Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review
    Aktar, Sharmin
    Baghaie, Hooman
    Islam, Farhadul
    Gopalan, Vinod
    Lam, Alfred King-Yin
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2023, 168 (05) : 988 - 1005
  • [27] Circulating tumor stem like cells in oral squamous cell carcinoma: An unresolved paradox
    Patel, Shanaya
    Shah, Kavan
    Mirza, Sheefa
    Shah, Kanisha
    Rawal, Rakesh
    [J]. ORAL ONCOLOGY, 2016, 62 : 139 - 146
  • [28] Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes
    T. M. Morgan
    X. Wang
    X. Qian
    J. M. Switchenko
    S. Nie
    K. R. Patel
    R. J. Cassidy
    D. M. Shin
    J. J. Beitler
    [J]. Clinical and Translational Oncology, 2019, 21 : 342 - 347
  • [29] Detection and clinical significance of circulating tumor cells in squamous cell carcinoma of the head and neck
    Chikamatsu, Kazuaki
    Takahashi, Hideyuki
    Sakakura, Koichi
    Toyoda, Minoru
    [J]. CANCER RESEARCH, 2016, 76
  • [30] Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck?
    Jatana, Kris R.
    Lang, Jas C.
    Chalmers, Jeffrey J.
    [J]. FUTURE ONCOLOGY, 2011, 7 (04) : 481 - 484